Reformulary_Logo.png
Canada’s first evidence-based medical cannabis formulary launches today
March 20, 2019 09:15 ET | Reformulary Group
TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- Reformulary Group, a Canadian healthcare technology company, today announced the launch of Cannabis Standard™ – the first evidence-based medical cannabis...
Reformulary_Logo.png
Starseed joins Cannabis Standard™ for Canadians, employers, physicians
September 12, 2018 09:24 ET | Reformulary Group
TORONTO, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Reformulary Group, Canada’s leading independent drug plan management company, today announced it has signed Licensed Producer (LP) Starseed Medicinal Inc....
35429_logo-ewellnesscopy.jpg
eWellness Expands Sales Funnel To Include Major U.S. Oil & Gas Companies
September 04, 2018 09:00 ET | eWellness Healthcare Corp
Culver City, CA, Sept. 04, 2018 (GLOBE NEWSWIRE) -- eWellness Healthcare Corporation – (OTCQB: EWLL) – a provider of the state of the art PHZIO platform for the physical therapy (PT) and telehealth...
Reformulary_Logo.png
Reformulary Group signs Aphria to provide medical cannabis for employer plans
May 29, 2018 14:12 ET | Reformulary Group
TORONTO, May 29, 2018 (GLOBE NEWSWIRE) -- Reformulary Group, Canada’s leading, independent drug plan management company, today announced it has signed Leamington, Ontario-based cannabis producer...
Reformulary_Logo.png
Reformulary Group signs MedReleaf as first Licensed Producer for new medical cannabis formulary
May 22, 2018 11:40 ET | Reformulary Group
TORONTO, May 22, 2018 (GLOBE NEWSWIRE) -- Reformulary Group, Canada’s leading, independent drug plan management company, today announced it has signed MedReleaf as its first Licensed Producer of...